Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Other Non Operating Income (2016 - 2025)

Palisade Bio (PALI) has disclosed Other Non Operating Income for 15 consecutive years, with $59000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income fell 47.32% to $59000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $242000.0, a 58.2% decrease, with the full-year FY2024 number at $433000.0, down 44.84% from a year prior.
  • Other Non Operating Income was $59000.0 for Q3 2025 at Palisade Bio, down from $61000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $5.1 million in Q2 2021 to a low of $41000.0 in Q4 2024.
  • A 5-year average of $696000.0 and a median of $189000.0 in 2023 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 513200.0% in 2021, then tumbled 92.66% in 2023.
  • Palisade Bio's Other Non Operating Income stood at $5.1 million in 2021, then tumbled by 50.36% to $2.5 million in 2022, then crashed by 92.66% to $187000.0 in 2023, then plummeted by 78.07% to $41000.0 in 2024, then soared by 43.9% to $59000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Non Operating Income are $59000.0 (Q3 2025), $61000.0 (Q2 2025), and $81000.0 (Q1 2025).